急性髓细胞白血病是很难治愈的恶性肿瘤。
急性髓细胞白血病的发生始于骨髓中某个细胞的病变。
AML starts with a change to a single cell in the bone marrow.
目的研究老年初治急性髓细胞白血病（AML）的治疗。
Objective To study the therapy of previously untreated elderly patients with acute myeloid leukemia(AML. )
对于急性髓细胞白血病，白血病细胞通常是指原始细胞。
With AML, the leukemic cells are often referred to as blast cells.
急性髓细胞白血病还可细分为不同的类型，称之为亚型。
There are different types of AML. These are called subtypes.
目的：探讨急性髓细胞白血病(aml)的免疫表型特点。
Objective: To explore the characteristic of immunophenotyping in acute myeloid leukemia (AML).
探讨端粒酶活性在急性髓细胞白血病（AML）发生中的作用。
Objective:To evaluate the role of telomerase activity in development of acute myeloid leukemia.
目的研究改良FLAG方案治疗难治性急性髓细胞白血病(aml)的疗效。
Objective to evaluate the therapeutic effect of modified FLAG regimen in the management of refractory acute myeloid leukemia (AML).
造血干细胞移植(有时也称为骨髓移植)，是治疗急性髓细胞白血病的一种手段。
A stem cell transplant (sometimes called a bone marrow transplant) is a treatment used for some patients who have AML.
目的：探讨WT1基因及其蛋白产物在急性髓细胞白血病（AML）细胞的表达及临床意义。
Objective:To explore the expression and significance of the WT1 gene and proteins in patients with acute myelocytic leukemia(AML).
急性髓细胞白血病的分型也会影响其治愈率，如急性早幼粒细胞白血病的治愈率就相对较高。
Patients with certain subtypes of AML, such as acute promyelocytic leukemia (APL) have a higher chance of cure.
目的：研究急性髓细胞白血病(aml)联合化疗药物的体外敏感性及化疗药物间的相互作用。
Objective: To study the sensitivity in vitro and the interaction of drugs in combination chemotherapy for acute myeloblastic leukemia (AML).
结果显示，在23例急性髓细胞白血病患者中17例患者的骨髓白血病细胞上有IDO的表达；
The results showed that IDO expression was found in 17 out of 23 cases of acute myeloid leukemia cells;
目的研究急性髓细胞白血病(aml)的端粒酶活性表达情况，探讨端粒酶活性检测对AML的临床意义。
ObjectiveTo study the expression of telomerase activity in patients with acute myelocytic leukemia (AML) and its clinical significance.
我们进行了一项临床试验旨在分析伏立康唑在急性髓细胞白血病化疗诱导阶段预防肺部浸润的有效性和安全性。
We conducted a trial to analyze the efficacy and safety of voriconazole in the prevention of lung infiltrates during induction chemotherapy for acute myelogenous leukaemia (AML).
在急性髓细胞性白血病aml和急性淋巴细胞性白血病all中，原始的急性白血病细胞进展、形成多达上亿个的白血病细胞。
In acute myelogenous leukemia (AML) and acute lymphocytic leukemia (ALL), the original acute leukemia cell goes on to form about a trillion more leukemia cells.
在高倍镜下，见到的是急性髓母细胞白血病骨髓。
At high power, the bone marrow of a patient with acute myelogenous leukemia is seen here.
目的：评价自体造血干细胞移植对急性髓系白血病的改善效果。
OBJECTIVE: to evaluate effect of autologous hematopoietic stem cell transplantation on the treatment of acute AML.
在高倍镜下，见到的是急性髓母细胞白血病骨髓。在右侧中心处有一个孤立巨核细胞。
At high power, the bone marrow of a patient with acute myelogenous leukemia is seen here. There is one lone megakaryocyte at the right center.
给华盛顿大学捐赠细胞的该名女性患有急性髓性白血病，这是一种进展非常快的癌症，美国每年有13000人患病，其中8800人死亡。
The woman at Washington University had acute myelogenous leukemia, a fast-growing cancer that affects about 13,000 people a year in the United States and kills 8,800.
在任何一个亚型中，治疗均与急性髓系白血病转化率无关，包括骨髓原始细胞增多或有异常核型出现的患者。
Treatment was not linked to the rate of acute myeloid leukemia in any defined subgroup, including patients with an increase of marrow blasts or an unfavorable karyotype.
目的探讨急性髓系白血病-M4、M5亚型的细胞遗传学、免疫表型特征。
Objective To study the cytogenetic and immunophenotype features in acute monocytic leukemia(M5) and acute myelomonocytic leukemia(M4).
目的：探讨CD44单克隆抗体A3D8对人急性髓系白血病细胞株HL-60细胞增殖分化影响的分子作用机制。
Objective:To investigate the molecular mechanism of the effect of A3D8, an anti-CD44 monoclonal antibody on proliferation and differentiation of human HL-60 cells.
DR5在TRAIL介导的急性髓系白血病细胞凋亡中起重要的作用。
DR5 may play an important role in TRAIL-inducing apoptosis of AML cells.
探讨老年急性髓细胞性白血病的有效治疗方案。
To explore of the efficient treating method for acute myeloid leukemia in the elderly.
目的报道1例以CD7+和双重t（8；21）易位为特征的近四倍体克隆急性髓细胞性白血病（AML）。
Objective To report a case of acute myeloid leukemia (AML) with CD7 + near-tetraploid clones by doublet(8; 21).
髓系抗原阳性儿童急性淋巴细胞白血病临床特点及预后。
Childhood acute lymphoblastic leukemia with myeloid antigen expression and its prognosis.
“慢性”白血病少有或几乎没有母细胞。与急性白血病相比，“慢性淋巴细胞性白血病”和“慢性髓细胞性白血病”通常进程相对缓慢。
"Chronic" leukemias have few or no blast cells. "chronic lymphocytic leukemia" and "chronic myelogenous leukemia" usually progress slowly compared to acute leukemias.
“慢性”白血病少有或几乎没有母细胞。与急性白血病相比，“慢性淋巴细胞性白血病”和“慢性髓细胞性白血病”通常进程相对缓慢。
"Chronic" leukemias have few or no blast cells. "chronic lymphocytic leukemia" and "chronic myelogenous leukemia" usually progress slowly compared to acute leukemias.
应用推荐